Breaking News Instant updates and real-time market news.

MTUAY

MTU Aero Engines

$120.76 /

+6.34 (+5.54%)

14:57
02/17/22
02/17
14:57
02/17/22
14:57

MTU Aero Engines price target raised to EUR 232 from EUR 221 at Deutsche Bank

Deutsche Bank analyst Christophe Menard raised the firm's price target on MTU Aero Engines to EUR 232 from EUR 221 and keeps a Buy rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Acciona Energias downgraded to Sector Perform from Outperform at RBC Capital » 04:49
12/02/22
12/02
04:49
12/02/22
04:49
CRPAY

Acciona Energias

/

+

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Energy Action: » 04:45
12/02/22
12/02
04:45
12/02/22
04:45
$ECON

Economic Data

/

+

Energy Action: Oil prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
EDP Renovaveis downgraded to Underperform from Sector Perform at RBC Capital » 04:44
12/02/22
12/02
04:44
12/02/22
04:44
EDRVF

EDP Renovaveis

$22.85 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDRVF EDP Renovaveis
$22.85 /

+ (+0.00%)

10/19/22 JPMorgan
EDP Renovaveis price target lowered to EUR 23 from EUR 24.50 at JPMorgan
10/13/22 Goldman Sachs
EDP Renovaveis downgraded to Neutral from Buy at Goldman Sachs
09/20/22 Barclays
EDP Renovaveis price target raised to EUR 23.90 from EUR 20.10 at Barclays
09/16/22 Societe Generale
EDP Renovaveis price target raised to EUR 22 from EUR 21 at Societe Generale
Downgrade
Acciona downgraded to Underperform from Sector Perform at RBC Capital » 04:43
12/02/22
12/02
04:43
12/02/22
04:43
ACXIF

Acciona

$198.70 /

+18.7 (+10.39%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACXIF Acciona
$198.70 /

+18.7 (+10.39%)

11/21/22 Societe Generale
Acciona price target lowered to EUR 38 from EUR 43.20 at Societe Generale
11/21/22 Citi
Acciona downgraded to Sell from Neutral at Citi
09/28/22 RBC Capital
Acciona price target raised to EUR 190 from EUR 185 at RBC Capital
09/23/22 Citi
Acciona downgraded to Neutral from Buy at Citi
Downgrade
Kerry Group downgraded to Neutral from Buy at Citi » 04:41
12/02/22
12/02
04:41
12/02/22
04:41
KRYAY

Kerry Group

$94.48 /

-1.08 (-1.13%)

Citi analyst Lauren…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRYAY Kerry Group
$94.48 /

-1.08 (-1.13%)

12/01/22 JPMorgan
Kerry Group price target lowered to EUR 118 from EUR 135 at JPMorgan
10/28/22 Credit Suisse
Kerry Group price target lowered to EUR 117 from EUR 128 at Credit Suisse
10/04/22 Barclays
Kerry Group price target lowered to 120 GBp from 137 GBp at Barclays
09/30/22 Deutsche Bank
Kerry Group price target lowered to EUR 125 from EUR 135 at Deutsche Bank
Recommendations
Marvell price target lowered to $55 from $80 at Piper Sandler » 04:38
12/02/22
12/02
04:38
12/02/22
04:38
MRVL

Marvell

$45.38 /

-1.175 (-2.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$45.38 /

-1.175 (-2.52%)

MRVL Marvell
$45.38 /

-1.175 (-2.52%)

11/28/22 JPMorgan
Marvell price target lowered to $75 from $85 at JPMorgan
11/28/22 Oppenheimer
Marvell price target lowered to $80 from $90 at Oppenheimer
11/15/22 Credit Suisse
Marvell initiated with an Outperform at Credit Suisse
10/27/22 Jefferies
Meta commentary positive for datacenter semi names, says Jefferies
MRVL Marvell
$45.38 /

-1.175 (-2.52%)

MRVL Marvell
$45.38 /

-1.175 (-2.52%)

MRVL Marvell
$45.38 /

-1.175 (-2.52%)

MRVL Marvell
$45.38 /

-1.175 (-2.52%)

General news
BoJ's Tamura fuels speculation of policy review. » 04:35
12/02/22
12/02
04:35
12/02/22
04:35
$ECON

Economic Data

/

+

BoJ's Tamura fuels…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Salesforce downgraded to Peer Perform from Outperform at Wolfe Research » 20:41
12/01/22
12/01
20:41
12/01/22
20:41
CRM

Salesforce

$146.99 /

-13.01 (-8.13%)

Wolfe Research analyst…

Wolfe Research analyst Alex Zukin downgraded Salesforce to Peer Perform from Outperform. The anlayst says his thesis on the stock has changed with its growth "materially decelerating."

ShowHide Related Items >><<
CRM Salesforce
$146.99 /

-13.01 (-8.13%)

CRM Salesforce
$146.99 /

-13.01 (-8.13%)

12/01/22 Jefferies
Salesforce price target lowered to $230 from $240 at Jefferies
12/01/22 BofA
Salesforce price target lowered to $200 from $210 at BofA
12/01/22 RBC Capital
Salesforce price target lowered to $200 from $235 at RBC Capital
12/01/22 BMO Capital
Salesforce price target lowered to $172 from $180 at BMO Capital
CRM Salesforce
$146.99 /

-13.01 (-8.13%)

CRM Salesforce
$146.99 /

-13.01 (-8.13%)

CRM Salesforce
$146.99 /

-13.01 (-8.13%)

CRM Salesforce
$146.99 /

-13.01 (-8.13%)

Upgrade
Toronto-Dominion upgraded to Buy from Hold at Canaccord » 20:40
12/01/22
12/01
20:40
12/01/22
20:40
TD

Toronto-Dominion

$68.36 /

+1.66 (+2.49%)

Canaccord analyst Scott…

Canaccord analyst Scott Chan upgraded Toronto-Dominion Bank to Buy from Hold with a price target of C$103, up from C$95.

ShowHide Related Items >><<
TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

11/22/22 Scotiabank
Toronto-Dominion price target lowered to C$100 from C$101 at Scotiabank
11/18/22 National Bank
Toronto-Dominion price target lowered to C$103 from C$106 at National Bank
09/02/22 Keefe Bruyette
Toronto-Dominion upgraded to Outperform from Market Perform at Keefe Bruyette
08/26/22 Canaccord
Toronto-Dominion price target lowered to C$94.50 from C$96 at Canaccord
TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

TD Toronto-Dominion
$68.36 /

+1.66 (+2.49%)

Hot Stocks
Accenture acquires Fiftyfive5 » 20:34
12/01/22
12/01
20:34
12/01/22
20:34
ACN

Accenture

$302.65 /

+1.98 (+0.66%)

The company states:…

The company states: "Accenture has acquired Fiftyfive5, a customer insights and advisory business. The move will strengthen Accenture Song's ability to help clients tap data insights and performance marketing to accelerate growth and innovation across Australia and New Zealand."

ShowHide Related Items >><<
ACN Accenture
$302.65 /

+1.98 (+0.66%)

ACN Accenture
$302.65 /

+1.98 (+0.66%)

10/14/22 JPMorgan
Accenture price target lowered to $306 from $329 at JPMorgan
10/13/22 Wells Fargo
Wells sees some encouraging signs from emerging metaverse app economy
09/27/22 Alliance Global Partners
Perficient upgraded to Buy from Neutral at Alliance Global Partners
09/26/22 Barclays
Accenture price target lowered to $340 from $370 at Barclays
ACN Accenture
$302.65 /

+1.98 (+0.66%)

ACN Accenture
$302.65 /

+1.98 (+0.66%)

ACN Accenture
$302.65 /

+1.98 (+0.66%)

Hot Stocks
Anavex phase 2B/3 study of blarcamesine met primary and key secondary endpoints » 20:30
12/01/22
12/01
20:30
12/01/22
20:30
AVXL

Anavex

$8.85 /

+0.03 (+0.34%)

Anavex Life Sciences…

Anavex Life Sciences "announced positive topline results from its Phase 2b/3 ANAVEX(R)2-73-AD-004 clinical trial of oral ANAVEX2-73, or blarcamesine, for the treatment of mild cognitive impairment due to Alzheimer's disease, AD, and mild AD . ANAVEX(R)2-73 met the primary endpoints ADAS-Cog1 and ADCS-ADL2 and key secondary endpoint CDR-SB3 with statistically significant results. Next step, in light of this data, is meeting with regulatory authorities to discuss this data in the context of ongoing development with an aim to bring this therapy to patients in Europe, Asia-Pacific, and the U.S."

ShowHide Related Items >><<
AVXL Anavex
$8.85 /

+0.03 (+0.34%)

AVXL Anavex
$8.85 /

+0.03 (+0.34%)

06/23/22 Berenberg
Anavex initiated with a Buy at Berenberg
02/02/22 Cantor Fitzgerald
Anavex price target lowered to $16 from $27 at Cantor Fitzgerald
AVXL Anavex
$8.85 /

+0.03 (+0.34%)

AVXL Anavex
$8.85 /

+0.03 (+0.34%)

AVXL Anavex
$8.85 /

+0.03 (+0.34%)

Downgrade
Wolfe Research cuts Edwards Lifesciences to Peer Perform on macro, TAVR maturity » 19:51
12/01/22
12/01
19:51
12/01/22
19:51
EW

Edwards Lifesciences

$77.50 /

+0.28 (+0.36%)

, ABT

Abbott

$107.96 /

+0.46 (+0.43%)

, BSX

Boston Scientific

$46.16 /

+0.87 (+1.92%)

Wolfe Research analyst…

Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences (EW) to Peer Perform from Outperform. The analyst cites the company's two consecutive disappointing quarters catalyzing a "soul search", with bulls likely to attribute underperformance to the environment and bears concerned about TAVR market maturity. Polark adds that the truth is "probably in the middle", with U.S. TAVR center productivity slowing and with Abbott (ABT) and Boston Scientific (BSX) also expected to introduce TAVR products in 2023-2024.

ShowHide Related Items >><<
EW Edwards Lifesciences
$77.50 /

+0.28 (+0.36%)

BSX Boston Scientific
$46.16 /

+0.87 (+1.92%)

ABT Abbott
$107.96 /

+0.46 (+0.43%)

EW Edwards Lifesciences
$77.50 /

+0.28 (+0.36%)

12/01/22 Wolfe Research
Edwards Lifesciences downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 RBC Capital
Edwards Lifesciences price target lowered to $105 from $118 at RBC Capital
11/16/22 Evercore ISI
Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list
10/28/22 Cowen
Edwards Lifesciences price target lowered to $100 from $125 at Cowen
ABT Abbott
$107.96 /

+0.46 (+0.43%)

10/26/22 Mizuho
Abbott initiated with a Neutral at Mizuho
10/21/22 Barclays
Abbott post-earnings selloff seems overdone, says Barclays
10/20/22 RBC Capital
Abbott price target lowered to $126 from $132 at RBC Capital
BSX Boston Scientific
$46.16 /

+0.87 (+1.92%)

11/30/22 Lake Street
Apollo Endosurgery downgraded to Hold from Buy at Lake Street
11/29/22 Piper Sandler
Piper says Apollo Endosurgery can help Boston Scientific expand ELS franchise
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/01/22 Piper Sandler
Abiomed downgraded to Neutral from Overweight at Piper Sandler
EW Edwards Lifesciences
$77.50 /

+0.28 (+0.36%)

BSX Boston Scientific
$46.16 /

+0.87 (+1.92%)

ABT Abbott
$107.96 /

+0.46 (+0.43%)

ABT Abbott
$107.96 /

+0.46 (+0.43%)

EW Edwards Lifesciences
$77.50 /

+0.28 (+0.36%)

BSX Boston Scientific
$46.16 /

+0.87 (+1.92%)

ABT Abbott
$107.96 /

+0.46 (+0.43%)

EW Edwards Lifesciences
$77.50 /

+0.28 (+0.36%)

BSX Boston Scientific
$46.16 /

+0.87 (+1.92%)

ABT Abbott
$107.96 /

+0.46 (+0.43%)

Hot Stocks
OceanTech Acquisitions I announces stockholder approval to extend combination » 19:23
12/01/22
12/01
19:23
12/01/22
19:23
OTEC

OceanTech Acquisitions I

$10.32 /

+0.06 (+0.58%)

OceanTech Acquisitions…

OceanTech Acquisitions "announced that its stockholders have approved an extension of the date by which the Company must consummate a business combination from December 2, 2022 to June 2, 2023 at the special meeting of stockholders held on November 29, 2022. The Extension provides the Company with additional time to complete the previously announced proposed business combination with Majic Wheels Corp., a Wyoming corporation. On November 15, 2022, OceanTech entered into a definitive business combination agreement pursuant to which it would acquire Majic Wheels Corp., a Wyoming corporation (the "Target"). Upon the closing of the business combination, which is expected in the first quarter of 2023, the combined company will be named Majic Corp. Majic Corp. expects to remain listed on Nasdaq under the ticker symbol "MJWL" after the consummation of the Business Combination. "

ShowHide Related Items >><<
OTEC OceanTech Acquisitions I
$10.32 /

+0.06 (+0.58%)

Downgrade
Americanas SA downgraded to Sell from Neutral at Goldman Sachs » 19:20
12/01/22
12/01
19:20
12/01/22
19:20
BZWHF

Americanas SA

$22.75 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Irma Sgarz downgraded Americanas SA to Sell from Neutral with a price target of R$10, down from R$13, as part of a broader research note. The company has struggled to find a new equilibrium between growth and profitability in 2022, and the limited capital allocation flexibility and ongoing business transformations to integrate past acquisitions will limit the room for upward revisions to estimates or multiple expansion in 2023, the analyst tells investors in a research note.

ShowHide Related Items >><<
BZWHF Americanas SA
$22.75 /

+ (+0.00%)

11/11/22 Itau BBA
Americanas SA downgraded to Market Perform from Outperform at Itau BBA
11/09/22 JPMorgan
Americanas SA downgraded to Underweight from Neutral at JPMorgan
Downgrade
Magazine Luiza downgraded to Neutral from Buy at Goldman Sachs » 19:18
12/01/22
12/01
19:18
12/01/22
19:18
MGLUY

Magazine Luiza

$2.80 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Irma Sgarz downgraded Magazine Luiza to Neutral from Buy with price target of R$3.8, down from R$4.8, as part of a broader research note. The company has struggled to find a new equilibrium between growth and profitability in 2022, and the limited capital allocation flexibility and ongoing business transformations to integrate past acquisitions will limit the room for upward revisions to estimates or multiple expansion in 2023, the analyst tells investors in a research note.

ShowHide Related Items >><<
MGLUY Magazine Luiza
$2.80 /

+ (+0.00%)

12/23/21 Citi
Magazine Luiza initiated with a Neutral at Citi
Hot Stocks
Equinix CFO sells $1.75M in common stock » 19:10
12/01/22
12/01
19:10
12/01/22
19:10
EQIX

Equinix

$698.10 /

+7.95 (+1.15%)

In a regulatory filing,…

In a regulatory filing, Equinix disclosed that its CFO Keith Taylor sold 2.5K share of common stock on December 1st in a total transaction size of $1.75M.

ShowHide Related Items >><<
EQIX Equinix
$698.10 /

+7.95 (+1.15%)

EQIX Equinix
$698.10 /

+7.95 (+1.15%)

11/17/22 Deutsche Bank
Equinix price target raised to $680 from $635 at Deutsche Bank
11/14/22 RBC Capital
Equinix price target raised to $720 from $668 at RBC Capital
11/13/22 Citi
Equinix price target lowered to $750 from $810 at Citi
11/03/22 Credit Suisse
Equinix price target raised to $591 from $571 at Credit Suisse
EQIX Equinix
$698.10 /

+7.95 (+1.15%)

EQIX Equinix
$698.10 /

+7.95 (+1.15%)

EQIX Equinix
$698.10 /

+7.95 (+1.15%)

EQIX Equinix
$698.10 /

+7.95 (+1.15%)

Initiation
Amprius Technologies initiated with a Buy at B. Riley » 19:00
12/01/22
12/01
19:00
12/01/22
19:00
AMPX

Amprius Technologies

$10.14 /

-0.19 (-1.84%)

B. Riley analyst…

B. Riley analyst Christopher Souther initiated coverage of Amprius Technologies with a Buy rating and $14 price target.

ShowHide Related Items >><<
AMPX Amprius Technologies
$10.14 /

-0.19 (-1.84%)

AMPX Amprius Technologies
$10.14 /

-0.19 (-1.84%)

10/27/22 EF Hutton
Amprius Technologies initiated with a Buy at EF Hutton
10/13/22 Oppenheimer
Amprius Technologies initiated with an Outperform at Oppenheimer
AMPX Amprius Technologies
$10.14 /

-0.19 (-1.84%)

AMPX Amprius Technologies
$10.14 /

-0.19 (-1.84%)

Initiation
Enovix initiated with a Buy at B. Riley » 19:00
12/01/22
12/01
19:00
12/01/22
19:00
ENVX

Enovix

$12.28 /

-0.7 (-5.39%)

B. Riley analyst…

B. Riley analyst Christopher Souther initiated coverage of Enovix with a Buy rating and $19 price target.

ShowHide Related Items >><<
ENVX Enovix
$12.28 /

-0.7 (-5.39%)

ENVX Enovix
$12.28 /

-0.7 (-5.39%)

11/04/22 Janney Montgomery Scott
Janney starts Enovix with Buy after earnings sellofff
11/04/22 Janney Montgomery Scott
Enovix initiated with a Buy at Janney Montgomery Scott
11/02/22 Cowen
Enovix price target lowered to $25 from $36 at Cowen
10/27/22 EF Hutton
Enovix initiated with a Buy at EF Hutton
ENVX Enovix
$12.28 /

-0.7 (-5.39%)

ENVX Enovix
$12.28 /

-0.7 (-5.39%)

ENVX Enovix
$12.28 /

-0.7 (-5.39%)

Hot Stocks
Theratechnologies trading resumes  19:00
12/01/22
12/01
19:00
12/01/22
19:00
THTX

Theratechnologies

$2.11 /

-0.1 (-4.52%)

 
ShowHide Related Items >><<
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

11/30/22 JonesTrading
Theratechnologies initiated with a Buy at JonesTrading
11/17/22 Cantor Fitzgerald
Theratechnologies initiated with an Overweight at Cantor Fitzgerald
07/15/22 National Bank
Theratechnologies price target lowered to C$3.25 from C$3.75 at National Bank
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

Hot Stocks
Babcock & Wilcox and Chart Industries to collaborate on hydrogen generation » 18:48
12/01/22
12/01
18:48
12/01/22
18:48
BW

Babcock & Wilcox

$5.11 /

+0.52 (+11.34%)

, GTLS

Chart Industries

$137.34 /

-5.51 (-3.86%)

Babcock & Wilcox (BW)…

Babcock & Wilcox (BW) has entered into an agreement with Chart Industries (GTLS) to collaborate on the further deployment of B&W's BrightLoop hydrogen generation technology, utilizing Chart's integrated hydrogen liquefaction and cryogenic carbon capture equipment and expertise. This joint solution aims to provide economic generation of low-carbon hydrogen and supplies cost-effective, transportable forms of liquid hydrogen and carbon dioxide. B&W and Chart will also work together to develop sales and marketing strategies for potential commercial hydrogen and carbon capture customers and projects.

ShowHide Related Items >><<
GTLS Chart Industries
$137.34 /

-5.51 (-3.86%)

BW Babcock & Wilcox
$5.11 /

+0.52 (+11.34%)

BW Babcock & Wilcox
$5.11 /

+0.52 (+11.34%)

10/28/22 B. Riley
Babcock & Wilcox price target lowered to $8 from $12.50 at B. Riley
07/19/22 Craig-Hallum
Babcock & Wilcox initiated with a Buy at Craig-Hallum
GTLS Chart Industries
$137.34 /

-5.51 (-3.86%)

11/29/22 Citi
Halliburton should take equity stake in Chart Industries, says Citi
11/22/22 Goldman Sachs
Chart Industries downgraded to Neutral from Buy at Goldman Sachs
11/18/22 Piper Sandler
Chart Industries downgraded on higher leverage at Piper Sandler
11/18/22 Piper Sandler
Chart Industries downgraded to Neutral from Overweight at Piper Sandler
GTLS Chart Industries
$137.34 /

-5.51 (-3.86%)

BW Babcock & Wilcox
$5.11 /

+0.52 (+11.34%)

GTLS Chart Industries
$137.34 /

-5.51 (-3.86%)

Hot Stocks
Live Nation director Iovine acquires 13,740 common shares » 18:45
12/01/22
12/01
18:45
12/01/22
18:45
LYV

Live Nation

$73.55 /

+0.8 (+1.10%)

In a regulatory filing,…

In a regulatory filing, Live Nation Entertainment director Jimmy Iovine disclosed the purchase of 13,740 common shares of the company on December 1 at a price of $73.28 per share.

ShowHide Related Items >><<
LYV Live Nation
$73.55 /

+0.8 (+1.10%)

LYV Live Nation
$73.55 /

+0.8 (+1.10%)

11/30/22 Morgan Stanley
Live Nation price target lowered to $80 from $95 at Morgan Stanley
11/28/22 Citi
Live Nation upgraded to Buy from Neutral at Citi
11/22/22 Redburn
Redburn starts Live Nation with a Neutral
11/22/22 Redburn
Live Nation initiated with a Neutral at Redburn
LYV Live Nation
$73.55 /

+0.8 (+1.10%)

LYV Live Nation
$73.55 /

+0.8 (+1.10%)

LYV Live Nation
$73.55 /

+0.8 (+1.10%)

LYV Live Nation
$73.55 /

+0.8 (+1.10%)

Earnings
Netgear sees FY23 revenue up low to mid-single digits, consensus $985.01M » 18:41
12/01/22
12/01
18:41
12/01/22
18:41
NTGR

Netgear

$20.16 /

+0.54 (+2.75%)

Says expects to be able…

Says expects to be able to maintain mid to high single digit top-line growth from 2024 on. Sees FY23 operating margin 1%-2% in first half and 5%-6% in second half. Sees FY23 adjusted tax rate roughly 24%. Sees generating free cash flow at a rate of 200% of adjusted net income. Guidance taken from Analyst Day.

ShowHide Related Items >><<
NTGR Netgear
$20.16 /

+0.54 (+2.75%)

NTGR Netgear
$20.16 /

+0.54 (+2.75%)

07/28/22 BWS Financial
Netgear upgraded to Buy from Neutral at BWS Financial
04/28/22 Deutsche Bank
Netgear price target lowered to $22 from $25 at Deutsche Bank
04/19/22 Cowen
Netgear's Q1 miss suggests challenges to persist, says Cowen
04/18/22 BWS Financial
Netgear price target lowered to $27 from $30 at BWS Financial
NTGR Netgear
$20.16 /

+0.54 (+2.75%)

NTGR Netgear
$20.16 /

+0.54 (+2.75%)

Hot Stocks
Theratechnologies announces update from TH1902 study » 18:32
12/01/22
12/01
18:32
12/01/22
18:32
THTX

Theratechnologies

$2.11 /

-0.1 (-4.52%)

Theratechnologies…

Theratechnologies "announced that it has decided to pause the enrollment of patients in its Phase 1 clinical trial of TH1902, the Company's lead investigational peptide drug conjugate for the treatment of sortilin-expressing cancers. The Company plans to submit an amendment to its protocol to the U.S. Food and Drug Administration for approval. Theratechnologies voluntarily made the decision to pause enrollment and revisit the study design after consulting with its investigators. Efficacy results observed thus far were not convincing enough to pursue enrolling patients and did not outweigh the adverse events seen in some patients. As previously reported, these adverse events consist mainly of neuropathy and eye toxicity."

ShowHide Related Items >><<
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

11/30/22 JonesTrading
Theratechnologies initiated with a Buy at JonesTrading
11/17/22 Cantor Fitzgerald
Theratechnologies initiated with an Overweight at Cantor Fitzgerald
07/15/22 National Bank
Theratechnologies price target lowered to C$3.25 from C$3.75 at National Bank
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

Hot Stocks
Theratechnologies trading halted, news pending  18:28
12/01/22
12/01
18:28
12/01/22
18:28
THTX

Theratechnologies

$2.11 /

-0.1 (-4.52%)

 
ShowHide Related Items >><<
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

11/30/22 JonesTrading
Theratechnologies initiated with a Buy at JonesTrading
11/17/22 Cantor Fitzgerald
Theratechnologies initiated with an Overweight at Cantor Fitzgerald
07/15/22 National Bank
Theratechnologies price target lowered to C$3.25 from C$3.75 at National Bank
THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

THTX Theratechnologies
$2.11 /

-0.1 (-4.52%)

Hot Stocks
Crowdstrike CEO: Most companies would kill for our results » 18:24
12/01/22
12/01
18:24
12/01/22
18:24
CRWD

Crowdstrike

$124.06 /

+6.49 (+5.52%)

In an interview on…

In an interview on CNBC's Mad Money, George Kurtz said customers are embracing Crowdstrike and want to buy more of its products, especially at the enterprise level. Net retention rates are near all-time highs, he noted. Lots of SMB customers are in "wait and see mode" with interest rates rising, Kurtz added. They are putting purchases on hold resulting in "elongated sales cycles."

ShowHide Related Items >><<
CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

12/01/22 Redburn
Crowdstrike initiated with a Buy at Redburn
12/01/22 Wolfe Research
Crowdstrike downgraded to Peer Perform from Outperform at Wolfe Research
11/30/22 Truist
Crowdstrike price target lowered to $200 from $275 at Truist
11/30/22 RBC Capital
Crowdstrike price target lowered to $165 from $200 at RBC Capital
CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

CRWD Crowdstrike
$124.06 /

+6.49 (+5.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.